Delfi Medical Innovations is a world leader in tourniquet technology, development and evaluation. Delfi's patented products are designed to meet the unique needs of specialty patient groups, surgeons, operating-room nurses, surgical technologists and pre-hospital medics. Members of the Delfi team have been extensively involved in tourniquet development and evaluation for more than 20 years.

From the US Army - Tourniquet Recommendations
(July/August 2004)

Recent testing of many different types of potential battlefield tourniquets by the US Army’s Institute of Surgical Research (USAISR) was fully independent from the manufacturers of all of the tourniquets tested. In USAISR testing, Delfi EMT pneumatic tourniquets were successfully applied and successfully stopped blood flow in all trials on all volunteers. There were no failures of any kind using the Delfi EMT pneumatic tourniquet and pain scores were dramatically lower than all other devices tested.

Reference: "Testing of Battlefield Tourniquets" by Dr. Thomas Walters, US Army Institute of Surgical Research, presented at Advanced Technology Applications for Combat Casualty Care 2004 (ATACCC) Conference, published in the Conference Proceedings, Aug 16-18 2004, St. Petersburg Florida; http://www.usaccc.org/ataccc/).

"[Based on the US Army’s Institute of Surgical Research test results] ... it is recommended that the [Delfi] EMT pneumatic tourniquet be considered for issue to combat medics. Further, it is recommended that the [Delfi] EMT be issued for all medical evacuation vehicles and echelon I-III medical facilities."

"The [Delfi] EMT pneumatic tourniquet was wider and thus significantly less painful than any device tested and is much less likely to induce nerve damage".

Reference: Tourniquet recommendations from US Army’s Institute of Surgical Research (USAISR, Fort Sam Houston, Texas), circulated to US Forces 28 July 2004